Cited 10 times in
Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 금웅섭 | - |
dc.contributor.author | 이우중 | - |
dc.contributor.author | 이정심 | - |
dc.contributor.author | 조연아 | - |
dc.date.accessioned | 2017-10-26T07:14:42Z | - |
dc.date.available | 2017-10-26T07:14:42Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2234-1900 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/151790 | - |
dc.description.abstract | PURPOSE: To evaluate the clinical outcomes of patients who underwent radiation therapy with or without targeted molecular therapy for the treatment of spinal metastasis from renal cell carcinoma (RCC). MATERIALS AND METHODS: A total of 28 spinal metastatic lesions from RCC patients treated with radiotherapy between June 2009 and June 2015 were retrospectively reviewed. Thirteen lesions were treated concurrently with targeted molecular therapy (concurrent group) and 15 lesions were not (nonconcurrent group). Local control was defined as lack of radiographically evident local progression and neurological deterioration. RESULTS: At a median follow-up of 11 months (range, 2 to 58 months), the 1-year local progression-free rate (LPFR) was 67.0%. The patients with concurrent targeted molecular therapy showed significantly higher LPFR than those without (p = 0.019). After multivariate analysis, use of concurrent targeted molecular therapy showed a tendency towards improved LPFR (hazard ratio, 0.13; 95% confidence interval, 0.01 to 1.16). There was no difference in the incidence of systemic progression between concurrent and nonconcurrent groups. No grade ≥2 toxicities were observed during or after radiotherapy. CONCLUSION: Our study suggests the possibility that concurrent use of targeted molecular therapy during radiotherapy may improve LPFR. Further study with a large population is required to confirm these results. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | Korean Society for Therapeutic Radiology and Oncology | - |
dc.relation.isPartOf | RADIATION ONCOLOGY JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma | - |
dc.type | Article | - |
dc.publisher.location | Korea (South) | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Radiation Oncology | - |
dc.contributor.googleauthor | Sangjoon Park | - |
dc.contributor.googleauthor | Kyung Hwan Kim | - |
dc.contributor.googleauthor | Woo Joong Rhee | - |
dc.contributor.googleauthor | Jeongshim Lee | - |
dc.contributor.googleauthor | Yeona Cho | - |
dc.contributor.googleauthor | Woong Sub Koom | - |
dc.identifier.doi | 10.3857/roj.2016.01718 | - |
dc.contributor.localId | A05006 | - |
dc.contributor.localId | A03112 | - |
dc.contributor.localId | A04680 | - |
dc.contributor.localId | A00273 | - |
dc.relation.journalcode | J02592 | - |
dc.identifier.eissn | 2234-3164 | - |
dc.relation.journalsince | 2011~ | - |
dc.identifier.pmid | 27306772 | - |
dc.relation.journalbefore | ~2011 Journal of the Korean Society for Therapeutic Radiology and Oncology (대한방사선종양학회지) | - |
dc.subject.keyword | Molecular targeted therapy | - |
dc.subject.keyword | Neoplasm metastasis | - |
dc.subject.keyword | Radiotherapy | - |
dc.subject.keyword | Renal cell carcinoma | - |
dc.contributor.alternativeName | Koom, Woong Sub | - |
dc.contributor.alternativeName | Rhee, Woo Joong | - |
dc.contributor.alternativeName | Lee, Jeong Shim | - |
dc.contributor.alternativeName | Cho, Yeona | - |
dc.contributor.affiliatedAuthor | Rhee, Woo Joong | - |
dc.contributor.affiliatedAuthor | Lee, Jeong Shim | - |
dc.contributor.affiliatedAuthor | Cho, Yeona | - |
dc.contributor.affiliatedAuthor | Koom, Woong Sub | - |
dc.citation.volume | 34 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 128 | - |
dc.citation.endPage | 134 | - |
dc.identifier.bibliographicCitation | RADIATION ONCOLOGY JOURNAL, Vol.34(2) : 128-134, 2016 | - |
dc.date.modified | 2017-10-24 | - |
dc.identifier.rimsid | 45801 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.